Fondation Campus Biotech Geneva

What Fondation Campus Biotech Geneva does

Fondation Campus Biotech Geneva (FCBG) is a Geneva-based non-profit foundation established in 2013 that operates the "neuro @campusbiotech" initiative, uniting EPFL, UNIGE, HUG (Geneva University Hospitals), HEPIA, startups, and GESDA to advance brain research and develop next-generation neuromodulation therapies. The foundation functions as a shared research-infrastructure provider across approximately 20,000+ m² of facilities, with 51–100 employees, governed by CEO Nicolas Durand under a board chaired by UNIGE Rector Audrey Leuba. It serves academic researchers, clinical practitioners, and a small number of neurotechnology startups operating within the campus ecosystem.

FCBG's core offering consists of nine interconnected technology platforms: a 7 Tesla ultra-high field MRI for advanced brain imaging; a combined MEG/EEG and neuromodulation platform; a preclinical neuroscience platform for rodent, cellular, and tissue research; a virtual reality and digital engineering platform (VRD); a clinical sleep and biomarker research platform (CSR); a neural microsystems platform (NMP) for microfabrication of neural devices; a human cellular neuroscience platform (HCNP/NeuroNA); the Bertarelli Foundation Gene Therapy Platform for viral vector development; and an ISO 15189-accredited Genome Center — the only center in Switzerland accredited for complete human DNA analysis. An on-site HUG outpatient clinic for cerebral and mental health provides co-located clinical translation.

As a non-profit foundation, FCBG does not disclose revenue or commercial pricing; its operating model relies on institutional partnerships, competitive grants, and likely public-sector support. Recent activity includes the 2025 launch of the unified "neuro @campusbiotech" initiative, the 2026 Grand Prix scientifique NRJ–Institut de France awarded to affiliated researchers for neurotechnology work restoring motor function in paralyzed patients, the Prix Robert-Bing 2026 from the Swiss Neurological Society, and four ERC Advanced Grants totaling €10.7 million.

Name

Fondation Campus Biotech Geneva

Legal name

Fondation Campus Biotech Geneva

Website

https://fcbg.ch

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

51–100 employees

Short description

Geneva-based non-profit foundation operating the neuro @campusbiotech initiative, uniting EPFL, UNIGE, HUG, and HEPIA to provide shared neuroscience research infrastructure — including 7T MRI, MEG, gene therapy, and an ISO 15189 Genome Center — for academic and clinical users.

Ownership category

akta.pro rank

Product category

Neuroscience Research Infrastructure

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Electromedical & Electrotherapeutic Apparatus (3845), Services-Medical Laboratories (8071)

akta.pro primary industry

Translational Medicine & Biomarkers (HLAIALAF)

akta.pro secondary industries

Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK), Neurology/CNS Gene Therapies (HLAAACAH), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Single-Cell & Spatial Omics Discovery Platforms (target ID/validation, functional profiling) (HLAAAIAF)

Keywords

• Neuroscience research platforms
• Neurotechnology infrastructure
• Clinical neuroimaging services
• Brain research foundation
• Translational neuromodulation

Headquarters

HQ city

Geneva

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Others

Distribution channels1 record

Marketing channels4 records

Core offering

Fondation Campus Biotech Geneva operates the 'neuro @campusbiotech' initiative, providing shared neuroscience research infrastructure and ten technology platforms (7T MRI, M-EEG and neuromodulation, preclinical neuroscience, virtual reality, clinical sleep research, neural microsystems, human cellular neuroscience, gene therapy, an ISO 15189-accredited Genome Center, and the HUG outpatient brain and mental health clinic) to academic and clinical partners. It enables translational research in neuroscience, neuroengineering, and artificial intelligence, supporting the development of next-generation neuromodulation therapies by co-locating EPFL, UNIGE, HUG, HEPIA, startups, and GESDA on a single Geneva campus.

Product overview

neuro @campusbiotech is a unified neuroscience research initiative comprising ten distinct technology and clinical platforms. The ecosystem includes neuroimaging platforms (MRI), neurophysiology platforms (MEG/EEG, NMP), preclinical research (PNP), human cellular neuroscience (HCNP), virtual reality research (VRD), clinical and sleep research (CSR), gene therapy (Bertarelli), and genomic analysis (Genome Center). Additionally, an outpatient clinic provides direct clinical services. These platforms are interconnected and shared among partner institutions (EPFL, UNIGE, HUG, HEPIA) to advance brain research and develop next-generation neuromodulation therapies.

Differentiator

Problem solved

Functional benefit

Products and services

• Plateforme d'Imagerie par Résonance Magnétique (IRM) [Magnetic Resonance Imaging Platform]
• Plateforme M/EEG et Neuromodulation (MEG) [M-EEG and Neuromodulation Platform]
• Plateforme de Neurosciences Précliniques (PNP) [Preclinical Neuroscience Platform]
• Plateforme de Réalité Virtuelle et d'Ingénierie Digitale (VRD) [Virtual Reality and Digital Engineering Platform]
• Plateforme de Recherche Clinique et sur le Sommeil (CSR) [Clinical and Sleep Research Platform]
• Plateforme de Micro-Systèmes Neuronaux (NMP) [Neural Microsystems Platform]
• Plateforme de Neurosciences Cellulaires Humaines Neurona (HCNP) [Human Cellular Neuroscience Platform]
• Plateforme Fondation Bertarelli - Thérapie Génique [Bertarelli Foundation Gene Therapy Platform]
• Genome Center
• Clinique Ambulatoire de Santé Cérébrale et Mentale des HUG [HUG Outpatient Brain and Mental Health Clinic]

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Eight partnerships are on record, tiered core and supporting.

• EPFL (École Polytechnique Fédérale de Lausanne)coreStrategic or Co-development PartnerFounding institutional partner contributing excellence in neurotechnology, engineering, AI, and translational research. EPFL Vice-President Stéphanie Lacour supports Campus Biotech initiatives. Hosts neuroengineering and brain research groups.
• UNIGE (Université de Genève)coreStrategic or Co-development PartnerFounding institutional partner and host of neuro initiative leadership. Recteur Audrey Leuba serves as President of the Fondation. Hosts faculty researchers including Prof. Denis Jabaudon.
• HUG (Hôpitaux Universitaires de Genève)coreStrategic or Co-development PartnerClinical partner providing translation from research to patient care. Director General Robert Mardini leads hospital operations. Operates outpatient clinic for cerebral and mental health at Campus Biotech.
• HEPIA (Haute école du paysage, d'ingénierie et d'architecture)supportingStrategic or Co-development PartnerTechnical and engineering partner contributing expertise in materials science and neurotechnologies, creating links between fundamental research and technological development.
• GESDA (Geneva Science and Technology Accelerator)supportingStrategic or Co-development PartnerScience and technology accelerator partner contributing to the innovation ecosystem at Campus Biotech Geneva.
• Bertarelli FoundationsupportingStrategic or Co-development PartnerHosts Gene Therapy platform developing viral vectors for life sciences research and therapeutic applications.
• Switzerland InnovationsupportingStrategic or Co-development PartnerSwiss innovation network partner supporting Campus Biotech as a technology and innovation hub.
• Startups ecosystemsupportingStrategic or Co-development PartnerVarious startups operate within the Campus Biotech ecosystem, contributing to neurotechnology innovation and commercialization of research outcomes.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Janelia Research Campus (HHMI): HHMI's Ashburn, Virginia research campus operating shared advanced imaging, physiology, and computational neuroscience platforms for resident and visiting scientists. Highly comparable as a mission-aligned, foundation-funded multi-platform neuroscience research hub.
• Allen Institute for Brain Science: Seattle-based non-profit operating shared large-scale neuroscience research infrastructure (imaging, electrophysiology, transcriptomics, behavior) for the global research community. Closely comparable as a non-profit, multi-platform neuroscience hub providing shared infrastructure rather than commercial products.
• Max Planck Institute for Brain Research: Frankfurt-based Max Planck Institute operating shared neuroscience research infrastructure focused on neural circuits, systems neuroscience, and molecular/cellular brain research. Comparable as a publicly funded neuroscience institute with multi-platform research capabilities and international visiting researcher programs.
• Kavli Institute for Brain Science (Columbia): Columbia University-affiliated institute combining systems neuroscience, neural imaging, and theoretical neuroscience on a shared research platform model. Comparable as an academic multi-platform neuroscience hub with cross-disciplinary (engineering + neuroscience) emphasis similar to Campus Biotech Geneva.
• McGovern Institute for Brain Research (MIT): MIT-based research institute operating shared neuroimaging and neuroengineering platforms for fundamental and translational neuroscience. Comparable as an academic institute providing shared advanced neuroscience infrastructure (including 7T MRI) for affiliated and external researchers.
• Champalimaud Foundation (Champalimaud Research): Lisbon-based private non-profit foundation running the Champalimaud Centre for the Unknown, which houses neuroscience and cancer research programs with shared imaging, behavioral, and clinical platforms. Comparable as a non-profit foundation combining neuroscience research infrastructure with clinical translation.

Broad incumbents

• Karolinska Institutet (Department of Neuroscience): Stockholm-based medical university operating large-scale neuroscience and gene therapy research infrastructure integrated with clinical Karolinska University Hospital. Comparable as an academic-clinical neuroscience hub combining basic neuroscience, clinical translation, and gene therapy capabilities.
• Salk Institute for Biological Studies: La Jolla-based non-profit biological research institute with shared neuroscience and gene therapy infrastructure as part of a broader life sciences portfolio. Comparable as a non-profit research institute but with a broader mandate beyond neuroscience and lacking the EPFL/HUG-style clinical-engineering partnership.
• Cold Spring Harbor Laboratory: Non-profit research and education institution operating shared neuroscience and genomics infrastructure alongside broader biology programs. Comparable as a non-profit shared-research-infrastructure model but with broader life sciences scope than Campus Biotech's neuroscience focus.

Regional players

• Wyss Center for Bio and Neuroengineering (Geneva): Geneva-based non-profit translating neurotechnology research (brain-computer interfaces, neural devices, neuromodulation) into clinical applications. Highly comparable as a Geneva-based, foundation-structured neurotechnology translation hub with adjacent but non-overlapping platform focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/fondation-campus-biotech-geneva

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fondation Campus Biotech Geneva